Accessible, authoritative, independent
from The Cochrane Library
This Cochrane Clinical Answer evaluates angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists to prevent progression of diabetic kidney disease.
Sorry, it appears that you don't have a current subscription to COCHRANE CLINICAL ANSWERS.
A subscription to THE COCHRANE LIBRARY is required.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.